Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Van Cutsem

Showing results (311-320 of 499) with videos related to

Pageof 50
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 22, 2008
European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancerFlorian Lordick, Theo Ruers, Daniela E Aust, et al.
BMC Cancer|April 5, 2007
Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocksHeiko Fensterer, Bernhard Radlwimmer, Jörn Sträter, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2015
Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trialGuillem Argilés, Mark P Saunders, Fernando Rivera, et al.
The Lancet. Oncology|November 22, 2012
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trialJaafar Bennouna, Javier Sastre, Dirk Arnold, et al.
Future Oncology (London, England)|February 20, 2019
KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancerYung-Jue Bang, Eric Van Cutsem, Charles S Fuchs, et al.
JAMA Oncology|October 11, 2019
Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical TrialDavid H Ilson, Josep Tabernero, Aliaksandr Prokharau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximabBart Jacobs, Wendy De Roock, Hubert Piessevaux, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2022
<sup>18</sup>F-AlF-NOTA-Octreotide Outperforms <sup>68</sup>Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter StudyElin Pauwels, Frederik Cleeren, Térence Tshibangu, et al.
Journal of Gastroenterology and Hepatology|September 30, 2017
Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOWKei Muro, Jae Yong Cho, Gyorgy Bodoky, et al.
Nature Communications|November 29, 2023
PD-1<sup>-</sup> CD45RA<sup>+</sup> effector-memory CD8 T cells and CXCL10<sup>+</sup> macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinomaSarah Cappuyns, Gino Philips, Vincent Vandecaveye, et al.
Pageof 50

Showing results (311-320 of 499) with videos related to

Sort By:
Pageof 50
European Journal of Cancer (Oxford, England : 1990)|July 22, 2008
European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancerFlorian Lordick, Theo Ruers, Daniela E Aust, et al.
BMC Cancer|April 5, 2007
Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocksHeiko Fensterer, Bernhard Radlwimmer, Jörn Sträter, et al.
European Journal of Cancer (Oxford, England : 1990)|March 31, 2015
Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trialGuillem Argilés, Mark P Saunders, Fernando Rivera, et al.
The Lancet. Oncology|November 22, 2012
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trialJaafar Bennouna, Javier Sastre, Dirk Arnold, et al.
Future Oncology (London, England)|February 20, 2019
KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancerYung-Jue Bang, Eric Van Cutsem, Charles S Fuchs, et al.
JAMA Oncology|October 11, 2019
Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical TrialDavid H Ilson, Josep Tabernero, Aliaksandr Prokharau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximabBart Jacobs, Wendy De Roock, Hubert Piessevaux, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 20, 2022
<sup>18</sup>F-AlF-NOTA-Octreotide Outperforms <sup>68</sup>Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter StudyElin Pauwels, Frederik Cleeren, Térence Tshibangu, et al.
Journal of Gastroenterology and Hepatology|September 30, 2017
Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOWKei Muro, Jae Yong Cho, Gyorgy Bodoky, et al.
Nature Communications|November 29, 2023
PD-1<sup>-</sup> CD45RA<sup>+</sup> effector-memory CD8 T cells and CXCL10<sup>+</sup> macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinomaSarah Cappuyns, Gino Philips, Vincent Vandecaveye, et al.
Pageof 50